Klaviyo, Inc.

For the period ended Dec 31, 2025. Filed Feb 10, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 10, 2026

KVYO$20.43-1.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 8. Consolidated Balance Sheets

Consolidated Balance Sheets

	As of,
	December 31, 2025	December 31, 2024
Assets
Current assets:
Cash and cash equivalents	$1,064,875	$881,473
Restricted cash	738	375
Accounts receivable, net of allowance for doubtful accounts	60,714	43,095
Deferred contract acquisition costs, current	29,634	20,544
Prepaid expenses and other current assets	50,115	34,262
Total current assets	1,206,076	979,749
Property and equipment, net	80,341	48,200
Right-of-use assets, net	101,126	42,917
Deferred contract acquisition costs, non-current	47,769	32,527
Restricted cash, non-current	—	739
Prepaid marketing expense	132,849	153,346
Other non-current assets	12,443	15,830
Total assets	$1,580,604	$1,273,308
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$29,072	$14,579
Accrued expenses	125,159	99,828
Lease liabilities, current	24,757	20,989
Deferred revenue	103,245	64,497
Total current liabilities	282,233	199,893
Lease liabilities, non-current	95,991	32,449
Other non-current liabilities	5,820	6,979
Total liabilities	384,044	239,321
Stockholders’ Equity
Preferred stock: $0.001 par value; 100,000,000 and 100,000,000 shares authorized; 0 and 0 shares issued; 0 and 0 shares outstanding at December 31, 2025 and 2024, respectively.	—	—
Series A common stock: $0.001 par value; 3,000,000,000 and 3,000,000,000 shares authorized; 144,262,443 and 88,956,301 shares issued and outstanding at December 31, 2025 and 2024, respectively.	144	89
Series B common stock: $0.001 par value; 350,000,000 and 350,000,000 shares authorized; 159,899,668 and 183,801,332 shares issued and outstanding at December 31, 2025 and 2024, respectively.	160	184
Additional paid-in capital	2,073,209	1,878,899
Accumulated deficit	(876,953)	(845,185)
Total stockholders’ equity	1,196,560	1,033,987
Total liabilities and stockholders’ equity	$1,580,604	$1,273,308

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.